Oct 18 (Reuters) – Danish drugmaker H. Lundbeck said on Sunday that board chair Dorothea Wenzel will step down at its annual general meeting in 2027, with the board intending to elect former Novo
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)